Matches in Wikidata for { <http://www.wikidata.org/entity/Q90925991> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q90925991 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q90925991 description "scientific article published on 15 June 2018" @default.
- Q90925991 description "wetenschappelijk artikel" @default.
- Q90925991 description "наукова стаття, опублікована в червні 2018" @default.
- Q90925991 name "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 name "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 type Item @default.
- Q90925991 label "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 label "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 prefLabel "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 prefLabel "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 P1433 Q90925991-E736367B-CD74-4AEE-B69D-C23023D16FA6 @default.
- Q90925991 P1476 Q90925991-BAB23AF8-F38B-4914-A2F5-D953F17B6B67 @default.
- Q90925991 P2093 Q90925991-254C5E12-6E11-41FE-8817-DB1434227EFD @default.
- Q90925991 P2093 Q90925991-37F23452-8524-4015-A959-DA50B7F4E5CB @default.
- Q90925991 P2093 Q90925991-4B161124-B34E-4CB4-B055-4764D74D3964 @default.
- Q90925991 P2093 Q90925991-540C2E8E-5D77-4C63-A4C8-88C2AD6F351B @default.
- Q90925991 P2093 Q90925991-54F46396-80EB-43D9-88B7-FA380D4DF085 @default.
- Q90925991 P2093 Q90925991-66CC8C48-8C94-4EA8-ABE9-571554654E9A @default.
- Q90925991 P2093 Q90925991-7B99B4FD-C7EA-46E3-80FB-35C1C9BD9E9E @default.
- Q90925991 P2093 Q90925991-9739A00D-D9BB-45CA-8EB8-26873BE7D8C0 @default.
- Q90925991 P2093 Q90925991-9FE5561C-6429-466E-BA90-AF7D56A59024 @default.
- Q90925991 P2093 Q90925991-A12F348B-313E-4D0F-ABAC-D1F6AA725BC7 @default.
- Q90925991 P2093 Q90925991-A26A807A-9B2A-4D7D-A8B1-D3E35EA35ACF @default.
- Q90925991 P2093 Q90925991-CCA19BFD-38C8-428B-AA70-D2F1E4A7B8A9 @default.
- Q90925991 P2093 Q90925991-E0ED630B-3428-4675-A6E7-8885A55AD734 @default.
- Q90925991 P2093 Q90925991-E85B32C6-D493-4C00-BB32-1B218A26A572 @default.
- Q90925991 P2093 Q90925991-E9ED038E-37E8-4338-AA67-20501BFD51D2 @default.
- Q90925991 P304 Q90925991-D27B7542-0B34-454A-92A3-5E2AC3E80C9A @default.
- Q90925991 P31 Q90925991-12384739-382A-458E-A738-3BABBBE5BC73 @default.
- Q90925991 P356 Q90925991-A6E861BA-1575-4B68-A475-A5D6E8B501C5 @default.
- Q90925991 P433 Q90925991-5C89D2FD-51E1-4CEE-A60B-AD4E65971D41 @default.
- Q90925991 P478 Q90925991-8CDB48CB-7F18-431A-973A-FC3F239F9698 @default.
- Q90925991 P50 Q90925991-1D3854EB-9E37-49ED-AAAF-954DC299ECFA @default.
- Q90925991 P577 Q90925991-0FE9073C-0FD6-40B2-968B-ACC8C3B57533 @default.
- Q90925991 P698 Q90925991-3BD8D357-4C03-4536-AC2F-425B5691EA49 @default.
- Q90925991 P356 J.CLML.2018.06.013 @default.
- Q90925991 P698 30104176 @default.
- Q90925991 P1433 Q5133774 @default.
- Q90925991 P1476 "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
- Q90925991 P2093 "Angela Toro" @default.
- Q90925991 P2093 "Brenda Ernst" @default.
- Q90925991 P2093 "Brenda F Ginos" @default.
- Q90925991 P2093 "Craig Reeder" @default.
- Q90925991 P2093 "Grzegorz S Nowakowski" @default.
- Q90925991 P2093 "Heidi E Kosiorek" @default.
- Q90925991 P2093 "Jose F Leis" @default.
- Q90925991 P2093 "Joseph Colgan" @default.
- Q90925991 P2093 "Joseph R Mikhael" @default.
- Q90925991 P2093 "Leslie Padrnos" @default.
- Q90925991 P2093 "Luis Porrata" @default.
- Q90925991 P2093 "Patrick B Johnston" @default.
- Q90925991 P2093 "Stephen M Ansell" @default.
- Q90925991 P2093 "Thomas E Witzig" @default.
- Q90925991 P2093 "Thomas M Habermann" @default.
- Q90925991 P304 "664-672.e2" @default.
- Q90925991 P31 Q13442814 @default.
- Q90925991 P356 "10.1016/J.CLML.2018.06.013" @default.
- Q90925991 P433 "10" @default.
- Q90925991 P478 "18" @default.
- Q90925991 P50 Q79379347 @default.
- Q90925991 P577 "2018-06-15T00:00:00Z" @default.
- Q90925991 P698 "30104176" @default.